![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 27, 2022 11:30:25 AM
The future still looks pretty good here, doesn’t it ?
I think so…..
$$ ZYME $$
Recent ZYME News
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/22/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 11:10:31 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/02/2024 11:00:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:18:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:13:02 PM
- Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock • GlobeNewswire Inc. • 08/01/2024 08:10:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:07:14 PM
- Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 07/30/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:35:01 PM
- Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer • GlobeNewswire Inc. • 07/25/2024 08:30:00 PM
- Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate • GlobeNewswire Inc. • 07/22/2024 10:00:38 AM
- Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024 • GlobeNewswire Inc. • 07/11/2024 10:30:00 AM
- Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers • GlobeNewswire Inc. • 06/17/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:15:53 PM
- Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer • GlobeNewswire Inc. • 06/10/2024 10:00:00 AM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/28/2024 10:30:00 AM
- Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/30/2024 10:00:00 AM
- Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 • GlobeNewswire Inc. • 04/11/2024 10:00:00 AM
- Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/08/2024 10:00:00 AM
- Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors • GlobeNewswire Inc. • 03/28/2024 10:00:00 AM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/27/2024 10:00:00 AM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/07/2024 09:46:26 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 03/07/2024 09:36:50 PM
FEATURED ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM